Evaluating serum CXCL12, sCD22, Lp-PLA2 levels and ratios as biomarkers for diagnosis of Alzheimer's disease

doi:10.5498/wjp.v14.i3.380

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (884)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

HTML

420

Figures (1-2)

Tables (1-4)

Sum=575

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

102

Sum=185

Publishing Process of This Article

Item

Count

Browse

Download

Sum=104

Mar 19, 2024 (publication date) through May 12, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Psychiatry

ISSN

2220-3206

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Psychiatry. Mar 19, 2024; 14(3): 380-387
Published online Mar 19, 2024. doi: 10.5498/wjp.v14.i3.380

Table 3 Ratio analysis

Ratio indicator	AD group (n = 60)	Control group (n = 60)	P value
CXCL12/sCD22	3.3 ± 0.6	1.7 ± 0.4	< 0.001
Lp-PLA2/sCD22	8.0 ± 1.2	5.2 ± 0.9	< 0.05

AD: Alzheimer's disease.

Citation: Liu ZL, Hua FF, Qu L, Yan N, Zhang HF. Evaluating serum CXCL12, sCD22, Lp-PLA2 levels and ratios as biomarkers for diagnosis of Alzheimer's disease. World J Psychiatry 2024; 14(3): 380-387
URL: https://www.wjgnet.com/2220-3206/full/v14/i3/380.htm
DOI: https://dx.doi.org/10.5498/wjp.v14.i3.380